Category - New Drugs
Imfinzi Approved in the US for the Treatment of Resectable Non-Small Cell Lung Cancer Before and After Surgery
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
FDA Approves Niktimvo (axatilimab-csfr) for the Treatment of Chronic Graft-Versus-Host Disease (GVHD)
FDA Grants Accelerated Approval for Livdelzi (seladelpar) for the Treatment of Primary Biliary Cholangitis
FDA Approves Nemluvio (nemolizumab) for the Treatment of Adult Patients with Prurigo Nodularis
FDA Approves Yorvipath (palopegteriparatide) for the Treatment of Hypoparathyroidism in Adults
FDA Approves Enzeevu (aflibercept-abzv), a Biosimilar to Eylea
scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the Furoscix Indication in Heart Failure